MALVERN, PA--(Marketwire - February 14, 2008) - Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced financial results for the fourth quarter and the year ended December 31, 2007. The Company also highlighted important commercial and clinical development progress during the year 2007 and provided financial and operational guidance for 2008.
